22Jan
Blog: Cooley’s 2020 Life Sciences M&A Year in Review
General Trends in Life Sciences M&A - If 2019 was the year of life sciences mega-deals, 2020 was the year of COVID-19, as the global pandemic permeated every aspect of the dealmaking landscape, with the life sciences sector being no exception. COVID-19 drove unprecedented levels of collaboration among biopharmaceutical companies seeking to develop a vaccine, leading to an accelerated research and development process that allowed not just one—but two—vaccines to be approved by the FDA in...
By:
Cooley LLP
Related
As employers with operations in California had feared, Governor Gavin Newsom has signed AB 51, which...
Read More >
The United States Environmental Protection Agency (“EPA”) announced on October 22nd it had finaliz...
Read More >
The New York Times recently published an article discussing trends in the area of unlawful age discr...
Read More >
Aquatherm, LLC v. CentiMark Corp, 2019 BL 13240 (D. Utah Apr. 12, 2019) - Stag II Lindon LLC and St...
Read More >
Employer Created Hostile Work Environment By Discriminating Against Customers Based on Their Perceiv...
Read More >
Just last year, the California Supreme Court in Dynamex Operations West v. Superior Court (2018) 4 C...
Read More >